Literature DB >> 3610713

Optimization of beam weights under dose-volume restrictions.

M Langer, J Leong.   

Abstract

A basic problem in treatment planning is the selection of weights for a set of beams which will yield the largest tumor dose under constraints limiting the doses received in specified fractions of different normal tissue structures. This report describes a method for formulating and solving this optimization problem as a combinatorial linear program. An illustration is provided by a problem in planning treatment of a thoracic tumor, in which no more than 1/2 or 2/3 of the lung is permitted to receive greater than 20 Gy and no part of the spinal cord allowed to receive greater than 45 Gy. The optimization technique was applied to this example to determine how the maximum tumor dose is affected by changes in the normal tissue constraints and the addition of a tumor dose homogeneity restriction. The linear programming technique yielded a rigorous and efficient determination of the beam weights for the thoracic plan considered. An exhaustive specification of all the underlying linear programs allows problems of moderate dimensions to be solved, while developments in mathematical programming and computer processing suggest approaches to problems of greater complexity.

Entities:  

Mesh:

Year:  1987        PMID: 3610713     DOI: 10.1016/0360-3016(87)90203-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Designing radiotherapy plans with elastic constraints and interior point methods.

Authors:  Allen Holder
Journal:  Health Care Manag Sci       Date:  2003-02

2.  Integrating soft and hard dose-volume constraints into hierarchical constrained IMRT optimization.

Authors:  Sovanlal Mukherjee; Linda Hong; Joseph O Deasy; Masoud Zarepisheh
Journal:  Med Phys       Date:  2019-12-04       Impact factor: 4.071

3.  An Automatic Approach for Satisfying Dose-Volume Constraints in Linear Fluence Map Optimization for IMPT.

Authors:  Maryam Zaghian; Gino Lim; Wei Liu; Radhe Mohan
Journal:  J Cancer Ther       Date:  2014-02

4.  Accuracy of an automatic patient-positioning system based on the correlation of two edge images in radiotherapy.

Authors:  Myonggeun Yoon; Minho Cheong; Jinsung Kim; Dong Ho Shin; Sung Yong Park; Se Byeong Lee
Journal:  J Digit Imaging       Date:  2010-02-02       Impact factor: 4.056

5.  A comparison of the quality assurance of four dosimetric tools for intensity modulated radiation therapy.

Authors:  Jaeman Son; Taesung Baek; Boram Lee; Dongho Shin; Sung Yong Park; Jeonghoon Park; Young Kyung Lim; Se Byeong Lee; Jooyoung Kim; Myonggeun Yoon
Journal:  Radiol Oncol       Date:  2015-08-21       Impact factor: 2.991

6.  Feasibility study on the verification of actual beam delivery in a treatment room using EPID transit dosimetry.

Authors:  Tae Seong Baek; Eun Ji Chung; Jaeman Son; Myonggeun Yoon
Journal:  Radiat Oncol       Date:  2014-12-04       Impact factor: 3.481

Review 7.  Comparison of 3D CRT and IMRT Tratment Plans.

Authors:  Erjona Bakiu; Ervis Telhaj; Elvisa Kozma; Ferdinand Ruçi; Partizan Malkaj
Journal:  Acta Inform Med       Date:  2013

8.  A new homogeneity index based on statistical analysis of the dose-volume histogram.

Authors:  Myonggeun Yoon; Sung Yong Park; Dongho Shin; Se Byeong Lee; Hong Ryull Pyo; Dae Yong Kim; Kwan Ho Cho
Journal:  J Appl Clin Med Phys       Date:  2007-03-20       Impact factor: 2.102

9.  The effect of interfraction prostate motion on IMRT plans: a dose-volume histogram analysis using a Gaussian error function model.

Authors:  James C L Chow; Runqing Jiang; Daniel Markel
Journal:  J Appl Clin Med Phys       Date:  2009-09-30       Impact factor: 2.102

10.  Development of Optical Fiber Based Measurement System for the Verification of Entrance Dose Map in Pencil Beam Scanning Proton Beam.

Authors:  Jaeman Son; Se Byeong Lee; Youngkyung Lim; Sung Yong Park; Kwanho Cho; Myonggeun Yoon; Dongho Shin
Journal:  Sensors (Basel)       Date:  2018-01-15       Impact factor: 3.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.